United States of America

uber personal injury coverageAfter a night on the town, a taxi is no longer your only option to get back home. Uber, and other “ride-sharing” companies, have given the taxi companies a run for their money by offering cheap(er) and easier transportation. The idea is great: link drivers and those in need of a ride via a smartphone app, allow them to communicate with the tap of a finger, and get rid of on-the-spot payment.

Riders are happy because they can get from A to B cheaper and faster.  Drivers are happy because they can earn a living (or extra money) as a cab driver without dealing with the logistics of a cab company which have been historically some of America’s worst run businesses.  Of course, Uber is happy too because they make so much profit by brokering the transaction that their company may be worth as much as $40 billion.

Continue reading

There is a Calico Critters animal toy recall of over 3.3 million toys.  Reports link small bottles and pacifiers included with the toys to the choking deaths of young children.  The Calico Critter toys subject to the recall were sold at Walmart, Meijer and on Amazon between January 2000 and December 2021.

The Consumer Product Safety Commission (CPSC) announced the Calico Critters recall yesterday, citing multiple incidents where the small animal toys caused children to choke after placing the small pacifier or bottle in their mouths.

CPSC has received multiple reports of children choking on the Calico Critters accessories, which have caused a range of injuries and health complications. The recall is aimed at preventing further injuries and fatalities related to the toys, and ensuring that parents and caregivers are aware of the risks associated with these small accessories.

Phthalates are a group of chemical compounds that were developed in the early 20th century and have been used in a variety of industrial and consumer applications.

Most people have never heard of phthalates. But women who have suffered injuries from hair relaxers are now learning about this chemical that they never knew they had been exposed to until now.

History of Phthalates

Most of our hair relaxer uterine fibroid lawsuits involve women who require a hysterectomy to treat their condition.  But our lawyers are also seeing claims from victims who need a myomectomy to treat fibroids that chemical hair straighteners may have caused.

We believe myomectomy claims may also receive significant settlement compensation in the new hair relaxer class action lawsuit.

The page talks about myomectomy lawsuits in this litigation and speculates about the settlement payouts victims might receive. Elsewhere, we give you the latest hair relaxer lawsuit update tracking where we are in the litigation.

New scientific evidence has established a link between female cancers (ovarian and uterine) and long-term use of chemical hair relaxers. Luster’s Smooth Touch and Luster’s Pink are two famous chemical hair relaxers/straighteners. Many women who used Smooth Touch, Pink, or other Luster relaxer products and subsequently developed uterine cancer, ovarian cancer, uterine fibroids, or endometriosis may be able to file a hair relaxer lawsuit and get financial compensation. Hair relaxer cancer lawsuits are already being filed around the country. Hair relaxer cases in federal courts have already been consolidated into a new class action lawsuit.

This post will examine the recent medical evidence linking relaxers to uterine and ovarian cancer and the lawsuits against Luster Products Inc. regarding its Smooth Touch and Pink line of relaxer products.

About Luster’s Smooth Touch and Other Hair Relaxer Products

Federal health officials have issued a warning about certain heart valve replacement devices made by Abbott. These devices, called the Trifecta Valve and the Trifecta Valve with Glide Technology, may deteriorate much faster than other similar devices. This could lead to patients needing another surgery to replace the valve sooner than expected or even experiencing serious and life-threatening health problems.

The Trifecta and Trifecta GT valves are used to treat people with heart valve problems, specifically with the aortic heart valve, which is an important valve that helps the heart function properly. The valves are intended as a replacement for a diseased, damaged, or malfunctioning native or prosthetic aortic heart valve.

The FDA approved the first-generation Trifecta valve in 2011, but it is no longer sold – with good reason – in the United States. The Trifecta GT valve, which was approved in 2016, is currently the only Abbott heart valve replacement device still available in the United States.  It was approved with the hope that this new tissue valve would offer enhancements that would make the implantation process smoother, providing a solution to patients, even those with more challenging cases.

Plaintiff Richard Mosley, a resident of Kentucky, filed a consumer class action lawsuit against EzriCare LLC, EzriRx LLC, Delsam Pharma LLC, Global Pharma Healthcare Private Limited, and Aru Pharma Inc. for manufacturing, importing, selling, marketing, labeling, and distributing artificial tears contaminated with a rare and drug-resistant strain of Pseudomonas aeruginosa bacteria.  This is not really a personal injury lawsuit.  The focus here is refund for anyone who bought these products. The plaintiff seeks injunctive relief and restitution for the full purchase price of the artificial tear products. Our firm is just handling the personal injury eye drops lawsuits.  But we write about this lawsuit because the core allegation are the same as they would be for a Deslam or Ezricare personal injury or wrongful death claim

The Contamination

The artificial tears, which contain Carboxymethylcellulose Sodium 10 MG in 1 ml, are alleged to be adulterated and contaminated due to the Defendants’ violations of Current Good Manufacturing Processes. These violations include lack of appropriate microbial testing, formulation issues, and inadequate preservatives in multi-use bottles.

maple syrup urine diseaseBritain’s National Screening Committee has recommended screening every newborn infant for four additional disorders. One of these is maple syrup urine disease, a rare disorder that impacts only about 1 in 185,000 children.

But here is a crazy fact.  This abnormality occurs with far greater frequency in the Old Order Mennonite population.  Who much more frequently?

These people have an incidence rate of around 1 in 380 newborns.  That is incredible, right?   There is also a high frequency in Ashkenazi Jews,  although the incidence rate is much lower, approximately 1 in 50,000 (but still an almost four-fold greater risk).  

What Is Maple Urine Disease?

Maple syrup urine disease (MSUD), also known as branched-chain ketoaciduria, is a rare genetic metabolic disorder that affects the body’s ability to break down certain amino acids, which are the building blocks of proteins. The name “maple syrup urine disease” comes from the distinctive sweet, maple syrup-like odor of the urine of affected individuals.

MSUD is caused by mutations in genes that are responsible for the breakdown of branched-chain amino acids (BCAAs), namely leucine, isoleucine, and valine. These amino acids cannot be properly metabolized in individuals with MSUD, leading to the buildup of toxic byproducts in the body.

This genetic abnormality creates a real risk to the child by disrupting the normal function of amino acids inside the body which can prevent the body from digesting some forms of protein and processing certain amino acids.   These proteins can be toxic to the brain.  Symptoms range from mild, such as vomiting, to severity where the patient will have seizures and coma and, potentially, a brain injury. These symptoms can be turned around with a particular diet, generally, one that is low in protein.  This often means severe restrictions on meat, fish, eggs, dairy foods, whole grain flour, beans, and nuts. If untreated, the risk can go up to brain injury and death.

Symptoms

The symptoms of MSUD can vary in severity and may include poor feeding, vomiting, developmental delays, seizures, and a distinctive odor in the urine and sweat. If left untreated, the accumulation of toxic substances can lead to severe neurological problems and even coma.

Treatment

Treatment for MSUD typically involves a special low-protein diet that restricts BCAAs, along with dietary supplements and regular monitoring of blood amino acid levels. In some cases, individuals with MSUD may require medical formulas that are specially formulated to meet their nutritional needs while minimizing BCAA intake. Early diagnosis and prompt management are crucial to preventing the serious complications associated with MSUD.

Most Common Manifestation

The most common type of this condition manifests itself in the first week of the baby’s life, usually shortly after the baby’s first ingestion of milk.   One big sign:  the baby’s urine will smell similar to maple syrup, thus the name.

Continue reading

TriStar electric pressure cookers have a design flaw that sometimes allows the device to pressurize without the locked lid. This defect causes the lid to explode when opened and projects scalding hot liquids over anyone nearby.

Users have suffered severe burns and facial disfigurement due to the lid defect.  These injuries are awful to deal with and they did not have to happen.

Our firm is seeking new product liability cases from anyone seriously injured by a faulty TriStar pressure cooker device. Users who suffered burns or other injuries from their TriStar instant pressure cooker may be entitled to financial compensation.

Social Security Disability Insurance (SSDI) is a government program that is supposed to provide financial support to anyone who is unable to work because they have become permanently disabled due to an illness or injury. To qualify for SSDI benefits you have to file a disability claim with the Social Security Administration (SSA) and your claim must be approved.

Each year the SSA received over 2 million claims for disability benefits. The odds of getting a claim approved are not very good. Only about 35% of all SSDI claims are ultimately approved and only 30% of disability applications are approved at the initial stage. In some cases, disability claims are properly denied because the applicant is not truly disabled and simply does not meet the eligibility requirements. In many other cases, however, claims are denied for technical reasons which usually involves an incomplete application or insufficient medical documentation.

Chances of Disability Claim Success at Each Level

Contact Information